Neuraxis
NRXS
12 hedge funds and large institutions have $939K invested in Neuraxis in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
33% more funds holding
Funds holding: 9 → 12 (+3)
19% more capital invested
Capital invested by funds: $790K → $939K (+$150K)
2% more ownership
Funds ownership: 3.73% → 5.73% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$291K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$132K |
| 3 |
BlackRock
New York
|
+$5.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.22K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$28.1K |
NRXS Hedge Fund Activity: Q4 2024 in Review
12 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Neuraxis (NRXS) for Q4 2024, worth a combined $939K — up 19% from $790K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NRXS positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Parsons Capital Management, adding an estimated $291K. The largest seller was Bank of Montreal, cutting an estimated $28.1K.
- 12 institutional investors held Neuraxis (NRXS) as of Q4 2024, up from 9 in Q3 2024.
- Funds reported $939K of Neuraxis stock for Q4 2024, up 19% quarter-over-quarter.
- 3 funds opened new Neuraxis positions in Q4 2024 and 0 closed out, a net change of +3 holders.
- The largest Neuraxis buyer in Q4 2024 was Parsons Capital Management, an estimated $291K added.
- The largest Neuraxis seller in Q4 2024 was Bank of Montreal, an estimated $28.1K sold.
Based on aggregated 13F filings for Q4 2024.